)
)
)
LyGenesis
LyGenesis is transforming organ transplantation through a cell therapy platform that enables the growth of functioning ectopic organs in lymph nodes. Our lead program for end-stage liver disease is in Phase 2a trials and enables a single donor liver to treat multiple patients—creating scale, efficiency, and software-like margins. The cell therapy is minimally invasive and lowers risk compared to whole organ transplant. With pipeline programs in pancreas, kidney, and thymus, we’re positioned to redefine regenerative medicine.
Address
PittsburghPennsylvania
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)